David A. Siegel Clear Point Neuro, Inc. Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 132,400 shares of CLPT stock, worth $2.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
132,400Holding current value
$2.05 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding CLPT
# of Institutions
114Shares Held
8.38MCall Options Held
437KPut Options Held
199K-
Vanguard Group Inc Valley Forge, PA1.5MShares$23.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA656KShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA483KShares$7.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.68 Million0.0% of portfolio
-
Ubs Group Ag361KShares$5.59 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $379M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...